POS-ARI-ER Observational Study of Acute Respiratory Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Clinical Research Alliance for Infectious Diseases (ECRAID)
About this trial
Acute respiratory infections (ARI) are one of the most frequent reasons for hospital admission and antibiotic use, and can be caused by a broad range of pathogens, including respiratory viruses with proven epidemic potential, e.g. influenza and coronaviruses. The POS-ARI-ER study will focus on describing the different routine diagnostic and therapeutic practices in the work-up and treatment of ARI, as well as clinical outcomes across the patient population. In addition, POS-ARI-ER aims to characterise both the adult patient population with ARI presenting to acute hospital settings in Europe, and the aetiology of ARI in these patients.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Clinical suspicion of a new episode of acute respiratory tract infection, with onset in the last 10 days
Patient presents to an emergency room or secondary care setting
Informed consent is provided by patient or their legal representative
Disqualifiers
Patient has been transferred from another hospital
Patient admitted to hospital for >2 days at the time of enrolment
Patient has been previously enrolled in the POS-ARI-ER study
Trial design
Treatments tested in this trial
- Data collection
Treatment groups
No treatment groups listed
Sponsors and collaborators
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Lead sponsor
UMC Utrecht
Collaborator
University of Oxford
Collaborator
Source ClinicalTrials.gov